Clinical Utility of Multiple Blood Transfusion Products and the Management of Hematological Complications, Implications and Preventive Strategies among Oncological Patients: A Systematic Review
Jacques Forwah Ndeh, Ewa Anthony Obi, Edung Emen Samuel, Oluwagbenga Emmanuel Fatoba, Catherine Samuel Edung, Eze Godspower, Ohadiugha Uchenna Peter, Otonko Bernardine Osarr, Emefuru Juliet Adaku, Ukpabi Chiemerie, Portia Nomfundo Mzezewa, Habiba Abdulkadir, Ezinne Regina Okeoma, Chiamaka Nnenna Ukpabi, Ovia Stanley Chibueze, Chinonso Chimelu Ezeobi-Chris, Adeniran Adebayo Emmanuel, I. Kehinde Oluwagbeminiyi, Oliver X. Otu, Ike-Ogbonna Ginikachi Valerie, Blessing Festus Arimie, Okpara Camillus Chinweike, Idiege Idiege Omang, Immaculate Ihuoma Ekeagba & Abeshi Sylvester Etenikang · Asian Oncology Research Journal · 2026
Background: Patients with solid tumors and hematological malignancies frequently develop transfusion-dependent anemia from marrow infiltration and cytotoxic therapy. Multiple blood transfusions (MBT) sustain oxygen delivery but increase alloimmunization, iron overload, transfusio...